Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2029056
Max Phase: Preclinical
Molecular Formula: C48H91NaO18S
Molecular Weight: 989.31
Molecule Type: Small molecule
Associated Items:
ID: ALA2029056
Max Phase: Preclinical
Molecular Formula: C48H91NaO18S
Molecular Weight: 989.31
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 3'-O-Sulfated Sialyl Lewis X
Synonyms from Alternative Forms(1):
Canonical SMILES: CCCCCCCCCCCCCCC(CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)[O-])[C@H]2O)[C@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@H]1O.[Na+]
Standard InChI: InChI=1S/C48H92O18S.Na/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-34(29-27-25-23-21-19-17-15-13-11-9-7-5-2)32-60-46-42(56)45(65-47-40(54)39(53)37(51)33(3)61-47)43(36(31-50)63-46)64-48-41(55)44(66-67(57,58)59)38(52)35(30-49)62-48;/h33-56H,4-32H2,1-3H3,(H,57,58,59);/q;+1/p-1/t33-,35+,36+,37+,38-,39+,40-,41+,42+,43+,44-,45+,46+,47-,48-;/m0./s1
Standard InChI Key: YFBASYVPHDAEPI-NACWSHMVSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 989.31 | Molecular Weight (Monoisotopic): 988.6004 | AlogP: 5.10 | #Rotatable Bonds: 37 |
Polar Surface Area: 280.82 | Molecular Species: ACID | HBA: 17 | HBD: 9 |
#RO5 Violations: 4 | HBA (Lipinski): 18 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: -1.98 | CX Basic pKa: | CX LogP: 6.23 | CX LogD: 5.70 |
Aromatic Rings: 0 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: 1.19 |
1. Hiramatsu Y, Tsukida T, Nakai Y, Inoue Y, Kondo H.. (2000) Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model., 43 (8): [PMID:10780903] [10.1021/jm990342j] |
2. Hiramatsu Y, Moriyama H, Kiyoi T, Tsukida T, Inoue Y, Kondo H.. (1998) Studies on selectin blockers. 6. Discovery of homologous fucose sugar unit necessary for E-selectin binding., 41 (13): [PMID:9632363] [10.1021/jm9707481] |
3. Tsukida T, Hiramatsu Y, Tsujishita H, Kiyoi T, Yoshida M, Kurokawa K, Moriyama H, Ohmoto H, Wada Y, Saito T, Kondo H.. (1997) Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides., 40 (22): [PMID:9357520] [10.1021/jm970262k] |
4. Tsujishita H, Hiramatsu Y, Kondo N, Ohmoto H, Kondo H, Kiso M, Hasegawa A.. (1997) Selectin-ligand interactions revealed by molecular dynamics simulation in solution., 40 (3): [PMID:9022803] [10.1021/jm9606103] |
5. Tsukida T, Moriyama H, Kurokawa K, Achiha T, Inoue Y, Kondo H.. (1998) Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides., 41 (22): [PMID:9784103] [10.1021/jm980267x] |
6. Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728] [10.1016/j.ejmech.2017.10.015] |
Source(1):